Analysts Set Integer Holdings Corp (NYSE:ITGR) Target Price at $100.00

Integer Holdings Corp (NYSE:ITGR) has been given a consensus rating of “Buy” by the six brokerages that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $100.00.

Several research analysts have recently weighed in on the stock. TheStreet upgraded shares of Integer from a “c+” rating to a “b-” rating in a research note on Friday, May 8th. KeyCorp lowered their price objective on shares of Integer from $90.00 to $87.00 and set an “overweight” rating on the stock in a research note on Friday, May 8th. Sidoti boosted their price objective on shares of Integer from $100.00 to $108.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Benchmark assumed coverage on shares of Integer in a research note on Thursday, May 14th. They set a “buy” rating and a $105.00 price objective on the stock. Finally, ValuEngine upgraded shares of Integer from a “sell” rating to a “hold” rating in a research note on Friday, May 8th.

Integer stock opened at $67.38 on Friday. The firm has a market capitalization of $2.21 billion, a PE ratio of 21.12 and a beta of 1.20. The company’s 50-day moving average is $77.18 and its 200-day moving average is $77.91. Integer has a fifty-two week low of $46.01 and a fifty-two week high of $99.95. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.48 and a quick ratio of 1.56.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, May 7th. The medical equipment provider reported $1.25 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.19. The company had revenue of $328.43 million for the quarter, compared to analyst estimates of $305.20 million. Integer had a net margin of 8.32% and a return on equity of 14.30%. Integer’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.00 EPS. As a group, analysts expect that Integer will post 3.36 EPS for the current year.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Versant Capital Management Inc grew its position in shares of Integer by 1,976.5% during the 1st quarter. Versant Capital Management Inc now owns 706 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 672 shares in the last quarter. Tower Research Capital LLC TRC bought a new position in Integer in the 1st quarter valued at approximately $64,000. Meeder Asset Management Inc. lifted its stake in Integer by 2,219.4% in the 1st quarter. Meeder Asset Management Inc. now owns 1,670 shares of the medical equipment provider’s stock valued at $105,000 after purchasing an additional 1,598 shares during the last quarter. Point72 Hong Kong Ltd bought a new position in Integer in the 4th quarter valued at approximately $114,000. Finally, C M Bidwell & Associates Ltd. bought a new position in Integer in the 1st quarter valued at approximately $123,000. Institutional investors and hedge funds own 98.12% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.

See Also: What is Cost of Capital?

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.